BMY vs FCUV · P/E 17, rev $24.46B vs rev $723.1K
Bristol-Myers Squibb Company (BMY) versus Focus Universal Inc (FCUV) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Focus Universal Inc (FCUV) is a scientific & technical instruments company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FCUV revenue for 2026-06-30 was $723.1K. Net income was -$2.8M. FCUV currently screens at market cap $1.9M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FCUV currently screens at market cap $1.9M.
Not investment advice. Open the BMY and FCUV stock pages for the full models.
Not investment advice.